Laura A. Levit

3.1k total citations · 1 hit paper
47 papers, 1.8k citations indexed

About

Laura A. Levit is a scholar working on Public Health, Environmental and Occupational Health, Economics and Econometrics and Oncology. According to data from OpenAlex, Laura A. Levit has authored 47 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Public Health, Environmental and Occupational Health, 16 papers in Economics and Econometrics and 10 papers in Oncology. Recurrent topics in Laura A. Levit's work include Ethics in Clinical Research (11 papers), Economic and Financial Impacts of Cancer (11 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Laura A. Levit is often cited by papers focused on Ethics in Clinical Research (11 papers), Economic and Financial Impacts of Cancer (11 papers) and Health Systems, Economic Evaluations, Quality of Life (10 papers). Laura A. Levit collaborates with scholars based in United States, Germany and Australia. Laura A. Levit's co-authors include Jill Eden, Alfred O. Berg, Sally C. Morton, Sharyl J. Nass, Lawrence O. Gostin, Suanna S. Bruinooge, Arti Hurria, Michael A. Postow, Betty Ferrell and Heidi D. Klepin and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and The Lancet Oncology.

In The Last Decade

Laura A. Levit

40 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Finding What Works in Health Care: Standards for Systematic Reviews

2013 668 citations Jill Eden, Laura A. Levit et al. profile →

Peers

Laura A. Levit

PHEOH

ONCOL

GHP

SPU

Beth Devine United States

Nancy A Dreyer United States

Rachael Fleurence United States

Alex J Walker United Kingdom

Hendrik Koffijberg Netherlands

Melissa A. Robb United States

Joke C. Korevaar Netherlands

Juliet A. Usher‐Smith United Kingdom

Clare Bankhead United Kingdom

Rachel E. Sherman United States

Beth Devine United States

Laura A. Levit

579 ×1.1

PHEOH

258 ×0.6

ONCOL

325 ×0.8

300 ×0.8

GHP

186 ×0.8

SPU

Citations per year, relative to Laura A. Levit Laura A. Levit (= 1×) peers Beth Devine

Countries citing papers authored by Laura A. Levit

Since Specialization

Citations

This map shows the geographic impact of Laura A. Levit's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura A. Levit with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura A. Levit more than expected).

Fields of papers citing papers by Laura A. Levit

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura A. Levit. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura A. Levit. The network helps show where Laura A. Levit may publish in the future.

Co-authorship network of co-authors of Laura A. Levit

This figure shows the co-authorship network connecting the top 25 collaborators of Laura A. Levit. A scholar is included among the top collaborators of Laura A. Levit based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura A. Levit. Laura A. Levit is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Winer, Eric P., Laura A. Levit, Ethan Basch, et al.. (2025). Promoting Reasonable Career Expectations and Maximizing Professional Fulfillment for Academic Oncologists: ASCO Recommendations for Academic Medical Centers. Journal of Clinical Oncology. 43(17). 2017–2023. 2 indexed citations

Chino, Fumiko, Jill Jin, Laura A. Levit, et al.. (2025). Key Strategies to Promote Professional Wellness and Reduce Burnout in Oncology Clinicians. JCO Oncology Practice. 21(7). 936–941. 4 indexed citations

Schenkel, Caroline, Laura A. Levit, M. Kelsey Kirkwood, et al.. (2025). State of Professional Well-Being, Satisfaction, and Career Plans Among US Oncologists in 2023. PubMed. 2(2). e2400010–e2400010. 4 indexed citations

Balogh, Erin P., Laura A. Levit, Joseph M. Unger, et al.. (2025). ASCO State of Cancer Care in America Special Report 2025: Access to Cancer Clinical Trials in the United States. JCO Oncology Practice. 21(12). 1746–1758.

Kirkwood, M. Kelsey, Erin P. Balogh, Melissa Accordino, et al.. (2025). Where Have We Been and Where Are We Going? The State of the Hematology and Medical Oncologist Workforce in America. JCO Oncology Practice. 21(12). 1775–1785.

Levit, Laura A., Wim Ceelen, Mirjam Crul, et al.. (2025). Principles for advancing healthy workplace cultures: an ASCO–COSA–ECO joint statement. The Lancet Oncology. 26(10). 1270–1273.

Levit, Laura A., Elizabeth Garrett‐Mayer, Jeffrey Peppercorn, & Mark J. Ratain. (2024). Critical importance of correctly defining and reporting secondary endpoints when assessing the ethics of research biopsies. Clinical Trials. 21(5). 650–656.

Subbiah, Ishwaria M., et al.. (2023). Wellbeing and burnout among oncology fellows compared to prior fellows and current practicing oncologists: An ASCO State of Cancer Care in America (SOCCA) trend analysis.. JCO Oncology Practice. 19(11_suppl). 47–47.

Levit, Laura A., Caroline Schenkel, Lola A. Fashoyin‐Aje, et al.. (2023). Researcher Experience and Comfort With Telemedicine and Remote Patient Monitoring in Cancer Treatment Trials. The Oncologist. 29(4). 356–363. 3 indexed citations

10.

Levit, Laura A., Allison Magnuson, Dawn L. Hershman, et al.. (2021). Challenges and opportunities to developing a frailty index using electronic health record data. Journal of Geriatric Oncology. 12(5). 851–854. 8 indexed citations

11.

Tsimberidou, Apostolia M., Laura A. Levit, Richard L. Schilsky, et al.. (2018). Trial Reporting in Immuno-Oncology (TRIO): An American Society of Clinical Oncology-Society for Immunotherapy of Cancer Statement. Journal for ImmunoTherapy of Cancer. 6(1). 108–108. 15 indexed citations

12.

Hurria, Arti, Laura A. Levit, William Dale, et al.. (2015). Improving the Evidence Base for Treating Older Adults With Cancer: American Society of Clinical Oncology Statement. Journal of Clinical Oncology. 33(32). 3826–3833. 286 indexed citations

13.

Weber, Jeffrey S., Laura A. Levit, Peter C. Adamson, et al.. (2014). American Society of Clinical Oncology Policy Statement Update: The Critical Role of Phase I Trials in Cancer Research and Treatment. Journal of Clinical Oncology. 33(3). 278–284. 81 indexed citations

14.

Ferrell, Betty, Thomas J. Smith, Laura A. Levit, & Erin P. Balogh. (2014). Improving the Quality of Cancer Care: Implications for Palliative Care. Journal of Palliative Medicine. 17(4). 393–399. 16 indexed citations

15.

Ferrell, Betty, Mary S. McCabe, & Laura A. Levit. (2013). The Institute of Medicine Report on High-Quality Cancer Care: Implications for Oncology Nursing. Oncology nursing forum. 40(6). 603–609. 34 indexed citations

16.

Eden, Jill, Laura A. Levit, Alfred O. Berg, & Sally C. Morton. (2011). COMMITTEE ON STANDARDS FOR SYSTEMATIC REVIEWS OF COMPARATIVE EFFECTIVENESS RESEARCH. 54 indexed citations

17.

Levit, Laura A., Alison Smith, Edward J. Benz, & Betty Ferrell. (2010). Ensuring Quality Cancer Care Through the Oncology Workforce. Journal of Oncology Practice. 6(1). 7–11. 46 indexed citations

18.

Nass, Sharyl J., Laura A. Levit, & Lawrence O. Gostin. (2009). HIPAA, the Privacy Rule, and Its Application to Health Research. 2 indexed citations

19.

Nass, Sharyl J., Laura A. Levit, & Lawrence O. Gostin. (2009). The Value, Importance, and Oversight of Health Research. 15 indexed citations

20.

Nass, Sharyl J., Laura A. Levit, & Lawrence O. Gostin. (2009). The Value and Importance of Health Information Privacy. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact